Evidence map›Paper›PMID 25035667›Full record

ReviewTurkish journal of haematology : official journal of Turkish Society of Haematology2014

Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1).

Hamdi Akan, Seniz Ongören Aydın, Neşe Saltoğlu, Atahan Cağatay, Halis Akalın, Mutlu Arat, Rıdvan Ali, Sevgi Kalayoğlu-Beşışık, A Muzaffer Demir

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Turkish journal of haematology : official journal of Turkish Society of Haematology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Hamdi AkanAnkara University Faculty of Medicine Cebeci Campus, Department of Hematology, Ankara, Turkey.
Seniz Ongören Aydınİstanbul University Cerrahpaşa Faculty of Medicine, Department of Hematology, İstanbul, Turkey.
Neşe SaltoğluIstanbul University Cerrahpasa Faculty of Medicine, Department of Infectious Diseases, İstanbul, Turkey.
Atahan Cağatayİstanbul University Istanbul Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, İstanbul, Turkey.
Halis AkalınUludağ University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Bursa, Turkey.
Mutlu AratFlorence Nightingale Hospital, Hematology Unit, İstanbul, Turkey.
Rıdvan AliUludağ University Faculty of Medicine, Department of Hematology, Bursa, Turkey.
Sevgi Kalayoğlu-Beşışıkİstanbul University Cerrahpaşa Faculty of Medicine, Department of Hematology, İstanbul, Turkey.
A Muzaffer DemirTrakya University Faculty of Medicine, Department of Hematology, Edirne, Turkey.
Istanbul University-Cerrahpaşa · TRBursa Uludağ Üni̇versi̇tesi̇ · TRAnkara University · TRIstanbul Florence Nightingale Hospital · TRIstanbul University · TRTrakya University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The introduction of novel antifungal agents for the treatment of invasive fungal disease in hematological malignancies and also changing treatment strategies have had a great impact in managing affected patients. The medical literature includes some important clinical studies that are being used as evidence for guidelines. The problem with these studies and the guidelines is that they are not very easy to interpret, they include controversial issues, and they are not easy to apply to every patient or country. This paper was designed to critically show the main problems associated with these approaches and provide important information that will help Turkish doctors to adopt them in daily clinical practice.

Indexed as

Antifungal treatmentEvidenceHematological malignanciesinvasive fungal infection

Identifiers

PMID25035667
PMCPMC4102037
OpenAlexW2053283901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.